Theme: Innovative approaches for treatment of cancer
RADIOCANCER 2022
Conference Series extends its welcome to the Global Vitual Summit on Oncology and Radiology during DECEMBER 01-02 2022,as a webinar with a theme “Innovative approaches for treatment of cancer”. RADIOCANCER2022 Conference will focus on educational research directed toward its impact on clinical outcomes, through oral and poster presentations, educational workshop sessions, and influential plenary presentations. RADIOCANCER2022 is a perfect platform to find out how cancer and Oncology research innovations helpful to the Medical, Health and human society. Conference will mainly focus on the trending topics during presentations of the two-day event, which reflect current education, research, developments and innovations internationally in the field of cancer, oncology and medical sectors.
Why to attend:
Radiocancer 2022 is an international platform for presenting research about diagnosis, prevention and management and exchanging ideas about it and thus, contributes to the dissemination of knowledge in Oncology and Radiology for the benefit of both the academia and business.
The organizing committee of this Oncology and Radiology Conference is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the RADIOCANCER2022, where you will be sure to have a meaningful experience with scholars from all around the world. All members of the RADIOCANCER2022 Conference and Organizing Committee look forward to meeting you in conference. .
The International Research Conference is a allied association devoted to bringing together a significant number of different scholarly events for donation within the conference program. Events will run over a span of time during the conference depending on the number and length of the donations. With its high quality, it provides an exceptional value for scholars, academics and assiduity experimenters.
The end of this educational meeting is to partake up-to- date transnational guidelines for the care of TD and to apply them in clinical operation in diurnal practice. Interaction and exchange of experience and ideas will be enforced through clinical case studies and practice sessions. This is a best globalized opportunity to reach the largest assemblage of participants from the scientific community and research. Conduct presentations, meet with current, potential scientists, distribute information and make a splash with new cancer research developments, and receive name recognition at this event. Renowned speakers and therefore the most up-to-date techniques, developments, the most recent updates in oncology are hallmarks of this conference.
The global oncology medicines request size was valued at$ million in 2020, and is projected to reach$ million by 2030, registering a CAGR of7.5 from 2021 to 2030. Cancer is the third most murderous complaint in the world after cardiovascular, parasitic and contagious conditions. Chemoprevention is defined as pharmacological intervention with synthetic or naturally being composites that may inhibit or help carcinogenesis. Cancer treatment involves surgery, radiation and medicines. The surgery is the first line of remedy that's used for early stage of cancer. Radiotherapy is most frequently applied in a localized setting and confluence with surgical procedures. The last bone, medicines are enforced with chemotherapy (CTX), which employs a wide group of medicines that have cytotoxic goods. Targeted remedy is a type of cancer treatment that targets the changes in cancer cells that help them grow, divide, and spread.
The growth of the oncology/ cancer medicines request is driven by increase in frequence of cancer complaint and rise in prevalence of colorful cancer conditions, increase in fashionability of advance curatives ( natural and targeted medicine curatives), and swell in senior population worldwide. In addition, rise in cancer mindfulness, early webbing of the cancer also contributes toward growth of the oncology medicines request. Still, high cost involved in new medicine development coupled with trouble of failure & adverse goods associated with cancer medicines curatives pose to restrain the growth of the oncology/ cancer medicines request. Again, high eventuality of arising husbandry and advanced number of implicit medicines in the channel are anticipated to offer economic openings during the cast period.
1.Cancers of specific organs
Bladder cancer
Quite a few people with bladder cancer can have blood in their urine yet no pain while urinating. There are signs for bladder cancer like fatigue, weight loss, and bone tenderness, and these can display more progressive disease. Bladder Cancer occurs in men more normally than it does in women
Brain Cancer
A brain cancer holds the growth of abnormal cells in the tissues of the brain. Primary brain cancer comprises malignant tumour. Brain stem tumours, pituitary adenomas, germ cell tumour, Tumour development, of brain cancer, primary CNS lymphomas, Pathophysiology and Risk factors of brain cancer and prediction of brain tumours.
Breast cancer detection, Prevention and diagnosis
Breast cancer is most common in women. Screening tactics are therapeutic breast examination, mammography, and additional imaging methods. X-rays are taken to thoroughly detect the breast cancer which is well-known as a mammogram. After lump discovery or other sign mammogram is used.
Colorectal Cancer
Colorectal cancer starts in the colon. These cancers can also be entitled colon cancer or rectal cancer, reliant on where they start. Colon cancer and rectal cancer are often gathered together because they have many features in common.
2.Gynaecological cancers
Gynecologic cancers originate in different places within a woman’s pelvis, which is the area beneath the stomach and in between the hip bones.
Types of Gynecologic Cancer
Ovarian cancer originates in the ovaries, which are situated on each side of the uterus.
Uterine cancer originates in the uterus, the pear-shaped organ in a woman’s pelvis where the baby grows when she is pregnant.
Vaginal cancer begins in the vagina, which is the hollow, tube-like channel between the bottom of the uterus and the external of the body.
Vulvar cancer originates in the vulva, the outer part of the female genital organs.
3.Hematological Cancers Haematological malignancies are the types of cancer affecting blood, bone marrow and lymph nodes. They are denoted to as leukaemia, lymphoma and myeloma dependent on the type of cell affected.
Leukaemia People with leukaemia make a lot of white blood cells that can't fight infections.
Acute lymphocytic leukemia This starts in myeloid cells, which normally grow into white blood cells, red blood cells, and platelets. AML pull down the number of healthy blood cells in all three types. This procedure of leukaemia grows quickly.
Chronic lymphocytic leukemia This blood cancer starts in myeloid cells, like AML. But the abnormal cells develop slowly.
4.Cancer Biology Cancer is a disease of uncontrolled development and proliferation whereby cells have escaped the body’s standard growth control mechanisms and have gained the ability to distribute indefinitely. It is a multi-step process that involves the gathering of many genetic changes over time . These genetic alterations contain activation of proto-oncogenes to oncogenes, deregulation of tumour suppressor genes and DNA healing genes and ‘immortalisation’.
5.Cancer Immunotherapy & Vaccines
Immunotherapy is a kind of cancer treatment that helps your immune system battle cancer. Immunotherapy is a type of biological treatment. Biological treatment is a type of treatment that uses substances made from living organisms to treat cancer.
Immune checkpoint inhibitors, T-cell transfer therapy, Monoclonal antibodies, Monoclonal antibodies, Treatment vaccines, Immune system modulators.
6.Cancer Rehabilitation: Cancer rehabilitation is a program that comforts people with cancer and restore their physical and emotional well-being. Cancer rehabilitation is available before, and after cancer treatment
7.Mylenoma : Myeloma is a type of blood cancer that advances from cells in the bone marrow called plasma cells. It develops when there is a change in the DNA of the plasma cells. The modification happens to the DNA when the bone marrow is building new plasma cells. These are myeloma cells. Myeloma cells produce abnormal form of antibodies which doesn’t function properly hence they can’t fight infections.
8.Retinoblastoma
Retinoblastoma is a cancer that starts in the retina, It is the most common type of eye cancer in children. The obvious sign of retinoblastoma is an unusual appearance of the retina as viewed through the pupil, the medical term for which is leukocoria, also known as amaurotic cat's eye reflex. Other signs and symptoms include deterioration of vision, a red and irritated eye with glaucoma, and faltering development or delayed development. Some children with retinoblastoma can develop a cross-eyed. Retinoblastoma presents with advanced disease in emerging countries and eye enlargement is a common finding.
9.Cancer Biology Cancer is a disease of uncontrolled development and proliferation whereby cells have escaped the body’s standard growth control mechanisms and have gained the ability to distribute indefinitely. It is a multi-step process that involves the gathering of many genetic changes over time . These genetic alterations contain activation of proto-oncogenes to oncogenes, deregulation of tumour suppressor genes and DNA healing genes and ‘immortalisation’.
10.Radiation Therapy for Cancer Radiation therapy (also called radiotherapy) is a cancer therapy that uses high doses of radiation to kill cancer cells and shrink tumors .At low doses, radiation is used in x-rays to see exclusive your body,as with x-rays of your teeth or broken bones. At high doses, radiation therapy kills cancer cells or reduces their growth by damaging their DNA. Cancer cells whose DNA is damaged beyond repair stop isolating or die. When the damaged cells die, they are broken down and detached by the body.
11.Tumour screening and clinical management
Secondary prevention Method in which previous therapeutic intervention is possible through screening an asymptomatic population to recognize cancer at an earlier stage than it would have been diagnoised in absence of screening.
There are 3 national screening programmes
Bowel cancer screening is seen in people aged 60-74
Breast cancer screening is offered to women, some transgender men and certain non-binary people aged 50-70
Cervical screening is seen in women, some transgender men and some non-binary people aged 25-64
12.Carcinogens in cosmetics
Certain carcinogens, for example formaldehyde and formaldehyde-releasing additives are present in cosmetics. Formaldehyde are common carcinogens in skincare products, hair straightening products, nail polishes, shampoos, lotions, and shower gels. If humans are exposed to high quantities of formaldehyde, it can place them at a higher risk for developing cancers. Carcinogens may rise the risk of cancer by varying cellular metabolism or harmful DNA directly in cells, which interferes with biological methods, and encourages the uncontrolled, malignant partition, ultimately leading to the development of tumours.
13 Antineoplastic drugs
Most antineoplastic agents are categorized according to their structure or cell cycle activity - either cell cycle phase specific or cell cycle phase non-specific.
Cell cycle phase specific agents act on the cells in a particular phase. They are most active against tumours that have a huge proportion of cells vigorously moving through the cell cycle and cycling at a fast rate. Fast cycling ensures that the cell passes through the phase in which it is susceptible to the drugs' effects.
Cell cycle phase non-specific agents are not dependant on the cell being in a particular phase of the cell cycle for them to work - they disturb cells in all stages of the cell cycle. Resting cells (phase G0) are as vulnerable as dividing cells to the cytotoxic effects of these agents. As a result, phase non-specific agents have been found to be some of the most effective drugs against slow-growing tumours.
Generally, they are categorized as
(1)alkylating agents,
(2) antimetabolites,
(3) natural products,
(5) miscellaneous
Benefits of participation:
Advantages of Participating at our Webinar
- The advantages of the Speaker and abstract pages are created in Google on your profile under your name would get worldwide visibility.
- Our comprehensive online advertising attracts 30000+ users and 50000+ views to our Library of Abstracts, which takes researchers and speakers to our webinar.
- Meet with hundreds of like-minded experts who are pioneers in oncology and share ideas.
- All participants in the webinar would have a different reason to participate with eminent speakers and renowned keynote speakers in one-to-one meetings.
- A rare opportunity to listen what the world's experts are learning about from the world's most influential researchers in the area of cancer at our Keynote sessions.
- Onco summit intensive webinar schedule, you will acquire experience and expertise in strategic gift preparation that is worth its weight golf, forming an impressive array of recognised professionals.
- Best Poster Award nominations.
- Award for Outstanding Young Researcher.
- Group Registration Advantages.
Benefits of Participation for Speaker
- Worldwide appreciation of the profile of Researchers.
- Obtain credits for professional growth.
- Explore the latest of cutting edge analysis.
- Make long-term bonds at social and networking activities.
- An ability to advertise one page in the distribution of abstract books and flyers that ultimately gets 1 million views and adds great value to your research profile.
- Learn a transition beyond your area of interest to learn more about new subjects and studies away from your core subject of oncology.
- We have distinctive networking, learning and enjoyable integration into a single package.
Benefits of Participation for Delegate
- Professional Development-Improve understanding and knowledge.
- Attendance at webinars supports, rejuvenates and energises delegates.
- Your involvement in our webinar will help with a new methodology and ideology that can be used to broaden the outcomes of businesses or industries.
- Opportunities for Neuro Summit researchers and experts in the same field to meet and exchange new ideas through an online webinar.
Benefit of Participation for Sponsor
- Exposure to the international environment would increase the possibility of new companies.
- Opportunity to demonstrate your company's latest technologies, new products, or service your business to a wide range of international participants.
- Increase business by our webinar participants through lead generation.
- It takes a lot of time, effort and drive to create a successful company, so it's always nice to have a network of colleagues and associates to draw energy from individuals who share a common drive and objective.
- Webinars in neurology provide opportunities for more attention and contemplation that could help you move your company to the next stage.
- Benchmarking main organization plans and moving it forward.
- Get feedback from trustworthy people at our webinar to your company questions and challenges.
- On our webinar banner, website and other proceedings, branding and marketing content, the advertising logo of your company.
Benefit of Association for Collaborators
- Nobody has this massive visitors to oncology in the world, this is the best forum to highlight society.
- Creating long-lasting peer relationships.
- In our webinar banner, website and other proceedings, branding and marketing material, promotional content and your Organization logo will increase your number of subscribers/members by 40%.
- The exposure of our event to your Company listing in the Global Business forum will have a great effect on your association.
- Your representatives can network to update their knowledge and understanding of your organisation and services with key webinar delegates.
- Neurology advertising materials such as posters, brochures, pamphlets, services that will be circulated to hospitals, universities, society and researchers will be integrated with information.
Conference Highlights
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
Conference Date | December 01-02, 2022 | ||
Sponsors & Exhibitors |
|
||
Speaker Opportunity Closed | |||
Poster Opportunity Closed | Click Here to View |
Useful Links
Special Issues
All accepted abstracts will be published in respective Our International Journals.
Abstracts will be provided with Digital Object Identifier by